Insider trades
Jay R. Luly, CEO of Enanta Pharmaceuticals ENTA, has filed 1 purchase and 6 sales on the open market. Over the past 12 months that comes to a net sale of $67.5K. The latest trade was on 02/12.
Jay R. Luly
President and CEO
- Company
- Enanta Pharmaceuticals ENTA
- First filing
- 23/02/15
- Trades
- 28 trades
- Buys / sales
- 1 / 6
- 12-month net buying
- −$67.5K
- Last trade
- 02/12
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 25/12/05 | 25/12/05 | 4,743 sh | $14.23 | $67,492.89 | −0.5% | |
| Open-market buy | 25/02/12 | 25/02/12 | 45,000 sh | $5.69 | $256,050 | +5.6% | |
| Open-market sale10b5-1 plan | 24/12/06 | 24/12/10 | 5,142 sh | $8.06 | $41,444.52 | −0.6% | |
| Open-market sale | 23/12/05 | 23/12/06 | 7,230 sh | $9.63 | $69,624.9 | −0.9% | |
ENTA | Open-market sale | 23/03/13 | 23/03/14 | 27,912 sh3 trades | $45.16avg. | $1,260,628.34 | −3.3% |